The ceramide synthases (CerSs) activity assay was performed as described previously [13,24]. Briefly, cell lysates, prepared in an assay buffer (20 mM HEPES, pH 7.4, 25 mM KCl, 2 mM MgCl2, 0.5 mM DTT, 0.1% (w/v) fatty acid-free BSA, and 50 μM fatty acid-CoA (C16:0, C18:0, C20:0, C22:0, C24:0, and C26:0)) were incubated with 10 nmol of C17-sphinganine (Avanti Polar Lipids, Alabaster, AL, USA) for 30 min at 37 °C. Total lipids were extracted by the addition of CHCl3:MeOH (1:2, v/v), and 100 pmol of d17:1/C18:0 ceramide (Avanti Polar Lipids, Alabaster, AL, USA) was used as the internal standard, and applied onto the LC-ESI-MS/MS system (API 3200 QTRAP mass, AB/SCIEX, Framingham, MA, USA), as described previously [24]. The activity of CerS is expressed as pmol (d17:0 dihydroceramide production) per mg protein per min.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.